Quart Barry D
Insider CIK 1384243 · RDEA President and CEO, Director · KNSA Director · APPA Chief Executive Officer, Director · GEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals In | G Gift | 2026-08-19 | 2026-08-21 | 2,600 | — | $0 | 12,745 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | G Gift | 2026-08-19 | 2026-08-21 | 2,600 | — | $0 | 12,745 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,185 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-28 | 2026-04-29 | 13,099 | — | $0 | 13,237 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-04-28 | 2026-04-29 | 13,099 | $50.10 | $656.3K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-28 | 2026-04-29 | 13,099 | $14.33 | $187.7K | 25,645 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-06 | 2026-04-08 | 6,901 | — | $0 | 26,336 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-04-06 | 2026-04-08 | 6,901 | $50.00 | $345.1K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-06 | 2026-04-08 | 6,901 | $14.33 | $98.9K | 19,447 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-12 | 2026-02-12 | 2,690 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-12 | 2026-02-12 | 2,690 | $15.47 | $41.6K | 15,236 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-02-12 | 2026-02-12 | 2,690 | $45.00 | $121.0K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-10 | 2026-02-12 | 110 | — | $0 | 2,690 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-10 | 2026-02-12 | 110 | $15.47 | $1.7K | 12,656 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-02-10 | 2026-02-12 | 110 | $45.00 | $5.0K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-04 | 2026-02-04 | 2,602 | — | $0 | 2,800 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-02-04 | 2026-02-04 | 2,602 | $45.02 | $117.1K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-04 | 2026-02-04 | 2,602 | $15.47 | $40.3K | 15,148 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-03 | 2026-02-04 | 12,528 | — | $0 | 5,402 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-02-03 | 2026-02-04 | 12,528 | $45.27 | $567.1K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-03 | 2026-02-04 | 12,528 | $15.47 | $193.8K | 25,074 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-02 | 2026-02-04 | 830 | — | $0 | 17,930 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-02-02 | 2026-02-04 | 830 | $45.00 | $37.4K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-02 | 2026-02-04 | 830 | $15.47 | $12.8K | 13,376 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-12-15 | 2025-12-17 | 20,129 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-12-15 | 2025-12-17 | 20,129 | $10.36 | $208.5K | 32,675 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-12-15 | 2025-12-17 | 20,129 | $41.51 | $835.6K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-11 | 2025-06-11 | 12,336 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-11 | 2025-06-11 | 12,336 | $30.39 | $374.9K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-11 | 2025-06-11 | 12,336 | $3.80 | $46.9K | 24,882 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-10 | 2025-06-11 | 8,212 | — | $0 | 12,336 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-10 | 2025-06-11 | 8,212 | $3.80 | $31.2K | 20,758 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-10 | 2025-06-11 | 8,212 | $30.36 | $249.3K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-09 | 2025-06-11 | 6,900 | — | $0 | 20,548 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-09 | 2025-06-11 | 6,900 | $30.26 | $208.8K | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-09 | 2025-06-11 | 6,900 | $3.80 | $26.2K | 19,446 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 2,799 | — | $0 | 2,799 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 16,798 | — | $0 | 16,798 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 9,373 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 19,040 | — | $0 | 19,040 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 3,173 | — | $0 | 3,173 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 4,373 | — | $0 | 4,373 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 26,236 | — | $0 | 26,236 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2023-01-18 | 2023-01-20 | 850,000 | — | $0 | 850,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2023-01-13 | 2023-01-17 | 3,645 | — | $0 | 25,521 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2023-01-13 | 2023-01-17 | 16,122 | — | $0 | 114,807 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2023-01-13 | 2023-01-17 | 5,219 | $3.17 | $16.5K | 177,989 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2023-01-13 | 2023-01-17 | 16,122 | — | $0 | 183,208 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2023-01-13 | 2023-01-17 | 3,645 | — | $0 | 167,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-11-29 | 2022-12-01 | 21,959 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2022-11-29 | 2022-12-01 | 21,959 | $16.15 | $354.6K | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-11-29 | 2022-12-01 | 21,959 | $1.59 | $34.9K | 21,959 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2022-10-31 | 2023-01-17 | 1,655 | $3.27 | $5.4K | 163,441 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-10-13 | 2022-10-17 | 16,122 | — | $0 | 130,929 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-10-13 | 2022-10-17 | 3,646 | — | $0 | 29,166 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-10-13 | 2022-10-17 | 16,122 | — | $0 | 167,005 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-10-13 | 2022-10-17 | 5,219 | $3.76 | $19.6K | 161,786 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-10-13 | 2022-10-17 | 3,646 | — | $0 | 150,883 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-07-13 | 2022-07-15 | 3,646 | — | $0 | 32,812 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-07-13 | 2022-07-15 | 16,122 | — | $0 | 147,051 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-07-13 | 2022-07-15 | 16,122 | — | $0 | 152,456 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-07-13 | 2022-07-15 | 3,646 | — | $0 | 136,334 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-07-13 | 2022-07-15 | 5,219 | $3.01 | $15.7K | 147,237 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2022-04-29 | 2022-07-15 | 1,504 | $3.84 | $5.8K | 132,688 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-04-13 | 2022-04-15 | 16,122 | — | $0 | 163,173 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-04-13 | 2022-04-15 | 3,646 | — | $0 | 36,458 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-04-13 | 2022-04-15 | 5,219 | $6.07 | $31.7K | 131,184 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-04-13 | 2022-04-15 | 16,122 | — | $0 | 136,403 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-04-13 | 2022-04-15 | 3,646 | — | $0 | 120,281 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-01-13 | 2022-01-14 | 16,122 | — | $0 | 179,295 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-01-13 | 2022-01-14 | 3,646 | — | $0 | 40,104 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-01-13 | 2022-01-14 | 5,219 | $8.30 | $43.3K | 116,635 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-01-13 | 2022-01-14 | 16,122 | — | $0 | 121,854 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-01-13 | 2022-01-14 | 3,646 | — | $0 | 105,732 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2021-10-13 | 2021-10-15 | 390,834 | — | $0 | 390,834 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2021-10-13 | 2021-10-15 | 195,417 | — | $0 | 195,417 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-10-13 | 2021-10-15 | 3,646 | — | $0 | 43,750 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-10-13 | 2021-10-15 | 963 | $10.55 | $10.2K | 102,086 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-10-13 | 2021-10-15 | 3,646 | — | $0 | 103,049 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-07-13 | 2021-07-15 | 3,645 | — | $0 | 47,396 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-07-13 | 2021-07-15 | 3,645 | — | $0 | 100,366 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-07-13 | 2021-07-15 | 963 | $13.48 | $13.0K | 99,403 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-06-29 | 2021-06-30 | 33,237 | — | $0 | 33,237 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2021-04-30 | 2021-07-15 | 1,529 | $13.90 | $21.3K | 96,721 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-04-13 | 2021-04-15 | 3,646 | — | $0 | 51,041 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-04-13 | 2021-04-15 | 963 | $16.66 | $16.0K | 95,192 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-04-13 | 2021-04-15 | 3,646 | — | $0 | 96,155 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-01-13 | 2021-01-15 | 3,646 | — | $0 | 54,687 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-01-13 | 2021-01-15 | 963 | $18.16 | $17.5K | 91,909 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-01-13 | 2021-01-15 | 3,646 | — | $0 | 92,872 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-10-13 | 2020-10-15 | 58,333 | — | $0 | 58,333 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-10-13 | 2020-10-15 | 350,000 | — | $0 | 350,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-06-30 | 2020-07-02 | 18,760 | — | $0 | 18,760 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2020-04-30 | 2020-10-15 | 1,158 | $12.12 | $14.0K | 89,226 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-12-19 | 2019-12-23 | 325,000 | — | $0 | 325,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2019-10-03 | 2019-10-04 | 4,571 | $17.50 | $80.0K | 94,652 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-05-29 | 2019-05-30 | 18,760 | — | $0 | 18,760 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2019-04-30 | 2019-10-04 | 806 | $18.43 | $14.9K | 90,081 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2018-12-15 | 2018-12-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-09-14 | 2018-09-14 | 19,675 | — | $0 | 710,601 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-09-14 | 2018-09-14 | 19,675 | $7.20 | $141.7K | 89,275 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-06-21 | 2018-06-22 | 50,000 | — | $0 | 250,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-06-21 | 2018-06-22 | 50,000 | $9.05 | $452.5K | 119,600 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-06-21 | 2018-06-22 | 50,000 | $39.05 | $1.95M | 69,600 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2018-04-30 | 2018-06-22 | 1,607 | $13.22 | $21.2K | 69,600 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-03-19 | 2018-03-19 | 100,000 | — | $0 | 730,276 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-03-19 | 2018-03-19 | 100,000 | $7.20 | $720.0K | 167,993 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-03-19 | 2018-03-19 | 100,000 | $29.75 | $2.98M | 67,993 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-03-14 | 2018-03-16 | 100,000 | — | $0 | 830,276 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-03-14 | 2018-03-16 | 100,000 | $7.20 | $720.0K | 167,993 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-03-14 | 2018-03-16 | 100,000 | $24.75 | $2.48M | 67,993 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2017-12-18 | 2017-12-20 | 310,000 | — | $0 | 310,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2017-04-28 | 2017-12-20 | 1,684 | $12.62 | $21.3K | 67,993 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-12-21 | 2016-12-23 | 310,000 | — | $0 | 310,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | G Gift | 2016-11-04 | 2021-04-15 | 600 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | G Gift | 2016-11-04 | 2021-04-15 | 600 | — | $0 | 92,509 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2016-07-19 | 2016-07-20 | 4,630 | — | $0 | 930,277 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2016-07-19 | 2016-07-20 | 4,630 | $7.20 | $33.3K | 66,309 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2016-04-29 | 2016-07-20 | 837 | $18.22 | $15.3K | 61,679 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2016-03-02 | 2016-03-03 | 3,472 | — | $0 | 934,907 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2016-03-02 | 2016-03-03 | 3,472 | $7.20 | $25.0K | 60,842 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2015-12-28 | 2015-12-30 | 2,315 | — | $0 | 938,379 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2015-12-28 | 2015-12-30 | 2,315 | $7.20 | $16.7K | 82,370 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2015-12-22 | 2015-12-24 | 250,000 | — | $0 | 250,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2015-10-14 | 2015-10-15 | 10,000 | — | $0 | 940,694 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2015-10-14 | 2015-10-15 | 10,000 | $7.20 | $72.0K | 80,055 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2015-09-29 | 2015-09-30 | 14,306 | — | $0 | 950,694 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2015-09-29 | 2015-09-30 | 14,306 | $7.20 | $103.0K | 70,055 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2015-08-18 | 2015-08-19 | 10,000 | — | $0 | 965,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2015-08-18 | 2015-08-19 | 10,000 | $7.20 | $72.0K | 55,749 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 1,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 1,375 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 1,375 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 8,375 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 1,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 3,750 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 5,001 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2015-06-20 | 2021-04-15 | 600 | — | $0 | 600 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2015-04-30 | 2015-08-19 | 2,881 | $7.60 | $21.9K | 45,749 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2015-03-02 | 2015-03-04 | 10,000 | $13.07 | $130.7K | 42,868 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2014-12-12 | 2014-12-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | G Gift | 2014-12-12 | 2014-12-15 | 10,000 | — | $0 | 52,868 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | G Gift | 2014-12-12 | 2014-12-15 | 928 | — | $0 | 62,868 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2014-10-31 | 2014-12-15 | 1,941 | $7.50 | $14.6K | 63,796 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2014-06-25 | 2014-06-26 | 10,000 | $11.75 | $117.5K | 61,855 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 1,375 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-06-20 | 2014-06-24 | 1,375 | $100.00 | $137.5K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 1,375 | $25.00 | $34.4K | 1,375 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-17 | 2014-06-19 | 1,000 | — | $0 | 1,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-06-17 | 2014-06-19 | 1,000 | $90.00 | $90.0K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-17 | 2014-06-19 | 1,000 | $23.95 | $23.9K | 1,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-12 | 2014-06-16 | 1,000 | — | $0 | 8,375 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-06-12 | 2014-06-16 | 1,000 | $83.31 | $83.3K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-12 | 2014-06-16 | 1,000 | $23.00 | $23.0K | 1,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| APPA AP PHARMA INC /DE/ | A Award deriv | 2014-01-03 | 2014-01-07 | 2,733,333 | — | $0 | 2,733,333 | SEC↗ |
| APPA AP PHARMA INC /DE/ | P Buy | 2013-11-20 | 2013-11-21 | 1,000,000 | $0.40 | $400.0K | 1,037,100 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| APPA AP PHARMA INC /DE/ | A Award deriv | 2013-05-01 | 2013-05-03 | 22,500,000 | — | $0 | 22,500,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 105,000 | $28.10 | $2.95M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 9,003 | $17.05 | $153.5K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 150,000 | $21.32 | $3.20M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 189,460 | $16.31 | $3.09M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 10,540 | $16.31 | $171.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 90,997 | $17.05 | $1.55M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 149,721 | $13.06 | $1.96M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 5,279 | $13.06 | $68.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 145,774 | $8.34 | $1.22M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 4,226 | $8.34 | $35.2K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer | 2012-06-19 | 2012-06-20 | 43,348 | $32.00 | $1.39M | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2011-12-20 | 2012-01-11 | 15,000 | — | $0 | 15,000 | SEC↗ |